25
Earn 25 points
For patients with moderate-to-severe atopic dermatitis, persistent itch, disrupted sleep, and recurring flares can remain significant burdens despite ongoing treatment. With an expanding range of systemic therapies, clinicians have more to consider about treatment timing, early response, and the durability of disease control. In this Innovation Experience, clinicians examine the evidence and practical considerations informing these decisions, including recognizing inadequate control, setting meaningful treatment goals, and balancing long-term efficacy, safety, and patient preferences.
Earn 25 points
Earn 50 points
Earn 100 points